Abstract
We determined the free fraction of 25-dihydroxyvitamin D (25OHD) in the serum of subjects with clinical evidence of liver disease and correlated these measurements to the levels of vitamin D binding protein and albumin. These subjects when compared to normal individuals had lower total 25OHD levels, higher percent free 25OHD levels, but equivalent free 25OHD levels. These subjects also had reduced vitamin D binding protein and albumin concentrations. The total concentration of 25OHD correlated positively with both vitamin D binding protein and albumin, whereas the percent free 25OHD correlated negatively with vitamin D binding protein and albumin. The free 25OHD levels did not correlate with either vitamin D binding protein or albumin. We conclude that total vitamin D metabolite measurements may be misleading in the evaluation of the vitamin D status of patients with liver disease, and recommend that free 25OHD levels also be determined before making a diagnosis of vitamin D deficiency.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barragry J. M., Corless D., Auton J., Carter N. D., Long R. G., Maxwell J. D., Switala S. Plasma vitamin D-binding globulin in vitamin D deficiency, pregnancy and chronic liver disease. Clin Chim Acta. 1978 Aug 1;87(3):359–365. doi: 10.1016/0009-8981(78)90179-1. [DOI] [PubMed] [Google Scholar]
- Bengoa J. M., Sitrin M. D., Meredith S., Kelly S. E., Shah N., Baker A. L., Rosenberg I. H. Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease. Hepatology. 1984 Mar-Apr;4(2):261–265. doi: 10.1002/hep.1840040215. [DOI] [PubMed] [Google Scholar]
- Bikle D. D., Gee E., Halloran B., Haddad J. G. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest. 1984 Dec;74(6):1966–1971. doi: 10.1172/JCI111617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bikle D. D., Siiteri P. K., Ryzen E., Haddad J. G. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab. 1985 Nov;61(5):969–975. doi: 10.1210/jcem-61-5-969. [DOI] [PubMed] [Google Scholar]
- Bouillon R., Van Kerkhove P., De Moor P. Characteristics of the vitamin D binding protein in different species. Calcif Tissue Res. 1976 Aug;21 (Suppl):172–176. [PubMed] [Google Scholar]
- Eisman J. A., Shepard R. M., DeLuca H. F. Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. Anal Biochem. 1977 May 15;80(1):298–305. doi: 10.1016/0003-2697(77)90648-0. [DOI] [PubMed] [Google Scholar]
- Haddad J. G., Aden D. P., Kowalski M. A. Characterization of the human plasma binding protein for vitamin D and its metabolites synthesized by the human hepatoma-derived cell line, Hep 3B. J Biol Chem. 1983 Jun 10;258(11):6850–6854. [PubMed] [Google Scholar]
- Haddad J. G., Jr Transport of vitamin D metabolites. Clin Orthop Relat Res. 1979 Jul-Aug;(142):249–261. [PubMed] [Google Scholar]
- Hammond G. L., Nisker J. A., Jones L. A., Siiteri P. K. Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J Biol Chem. 1980 Jun 10;255(11):5023–5026. [PubMed] [Google Scholar]
- Hepner G. W., Roginsky M., Moo H. F. Abnormal vitamin D metabolism in patients with cirrhosis. Am J Dig Dis. 1976 Jul;21(7):527–532. doi: 10.1007/BF01464758. [DOI] [PubMed] [Google Scholar]
- Herlong H. F., Recker R. R., Maddrey W. C. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology. 1982 Jul;83(1 Pt 1):103–108. [PubMed] [Google Scholar]
- Horsting M., DeLuca H. F. In vitro production of 25-hydroxycholecalciferol. Biochem Biophys Res Commun. 1969 Jul 23;36(2):251–256. doi: 10.1016/0006-291x(69)90322-2. [DOI] [PubMed] [Google Scholar]
- Long R. G. Hepatic osteodystrophy: outlook good but some problems unsolved. Gastroenterology. 1980 Mar;78(3):644–647. [PubMed] [Google Scholar]
- Long R. G., Meinhard E., Skinner R. K., Varghese Z., Wills M. R., Sherlock S. Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut. 1978 Feb;19(2):85–90. doi: 10.1136/gut.19.2.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Long R. G., Skinner R. K., Wills M. R., Sherlock S. Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet. 1976 Sep 25;2(7987):650–652. doi: 10.1016/s0140-6736(76)92463-6. [DOI] [PubMed] [Google Scholar]
- Lund B., Sorensen O. H., Hilden M., Lund B. The hepatic conversion of vitamin D in alcoholics with varying degrees of liver affection. Acta Med Scand. 1977;202(3):221–224. doi: 10.1111/j.0954-6820.1977.tb16815.x. [DOI] [PubMed] [Google Scholar]
- Matloff D. S., Kaplan M. M., Neer R. M., Goldberg M. J., Bitman W., Wolfe H. J. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology. 1982 Jul;83(1 Pt 1):97–102. [PubMed] [Google Scholar]
- Mobarhan S. A., Russell R. M., Recker R. R., Posner D. B., Iber F. L., Miller P. Metabolic bone disease in alcoholic cirrhosis: a comparison of the effect of vitamin D2, 25-hydroxyvitamin D, or supportive treatment. Hepatology. 1984 Mar-Apr;4(2):266–273. doi: 10.1002/hep.1840040216. [DOI] [PubMed] [Google Scholar]
- Paterson C. R., Losowsky M. S. The bones in chronic liver disease. Scand J Gastroenterol. 1967;2(4):293–300. doi: 10.3109/00365526709180085. [DOI] [PubMed] [Google Scholar]
- Posner D. B., Russell R. M., Absood S., Connor T. B., Davis C., Martin L., Williams J. B., Norris A. H., Merchant C. Effective 25-hydroxylation of vitamin D2 in alcoholic cirrhosis. Gastroenterology. 1978 May;74(5 Pt 1):866–870. [PubMed] [Google Scholar]
- Reed J. S., Meredith S. C., Nemchausky B. A., Rosenberg I. H., Boyer J. L. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. Gastroenterology. 1980 Mar;78(3):512–517. [PubMed] [Google Scholar]
- Silver J., Fainaru M. Transport of vitamin D sterols in human plasma: effect of excess vitamin D, 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D. Eur J Clin Invest. 1979 Dec;9(6):433–438. doi: 10.1111/j.1365-2362.1979.tb00908.x. [DOI] [PubMed] [Google Scholar]
- Sitrin M., Meredith S., Rosenberg I. H. Vitamin D deficiency and bone disease in gastrointestinal disorders. Arch Intern Med. 1978 May 15;138(Spec No):886–888. [PubMed] [Google Scholar]
- Wagonfeld J. B., Nemchausky B. A., Bolt M., Horst J. V., Boyer J. L., Rosenberg I. H. Comparison of vitamin D and 25-hydroxy-vitamin-D in the therapy of primary biliary cirrhosis. Lancet. 1976 Aug 21;2(7982):391–394. doi: 10.1016/s0140-6736(76)92407-7. [DOI] [PubMed] [Google Scholar]
- Walsh P. G., Haddad J. G. "Rocket" immunoelectrophoresis assay of vitamin D-binding protein (Gc globulin) in human serum. Clin Chem. 1982 Aug;28(8):1781–1783. [PubMed] [Google Scholar]